SBIR-STTR Award

Maldi TOF MS For Genetic Bit Analysis On Microchip
Award last edited on: 5/14/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$98,613
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Xian-Wei Yao

Company Information

Orchid Biocomputer Inc

5210 Eastern Avenue Alpha Center
Baltimore, MD 21224
   N/A
   N/A
   N/A
Location: Single
Congr. District: 03
County: Baltimore City

Phase I

Contract Number: 1R43GM060764-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$98,613
Microarray chip-based technology is a promising and emerging technique that has great potential for rapid and high through-put genetic screening. Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) is a detection method that offers speed, sensitivity, accuracy and automation. The objective of this study is to demonstrate the feasibility of solid phase Genetic Bit Analysis (GBA) for single nucleotide polymorphisms (SNPs) analysis using MALDI-TOF MS as the detection method. Our goals will be to: (1) demonstrate the feasibility of using mass labeled ddNTPs incorporated into GBA primers for subsequent detection in MALDI-TOF MS, (2) develop a solid phase chemistry that will allow GBA primers to be uncoupled from a solid surface for subsequent analysis by MALDI-TOF MS. (3) demonstrate SNP analysis by GBA using MALDI-TOF MS detection for genotype calling on a micro chip. The success of this Phase I study will allow the development of a microarray GBA diagnostic chip capable of analyzing SNPs by MALDI-TOF MS detection. PROPOSED COMMERCIAL APPLICATIONS: The direct application of MALDI-TOF MS detection to solid phase GBA will result in an advanced version of GBA, which provides a number of advantages over traditional fluorescence or ELASA based detection methods. Specifically, it permits rapid, one-step, accurate mass-based separation with the possibility of automation.

Thesaurus Terms:
genetic polymorphism, genetic technique, matrix assisted laser desorption ionization, nucleic acid quantitation /detection, technology /technique development DNA primer, biomedical automation, nucleic acid chemical synthesis

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----